Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Psoriasis Modeling

Psoriasis is a chronic immune-mediated skin disorder characterized by epidermal hyperproliferation, inflammatory infiltration, and abnormal keratinization. Commonly used mouse models include imiquimod (IMQ)-induced models, IL-23 injection, and transgenic approaches. These models are widely applied to evaluate cytokine networks, the Th17/IL-23 signaling axis, and the efficacy of small-molecule targeted therapies.

Imiquimod hydrochloride
T2209199011-78-6
Imiquimod hydrochloride (R 837 hydrochloride), a selective toll-like receptor 7 (TLR7) agonist, functions as an immune response modifier with in vivo antiviral and antitumor properties, and is utilized in researching external genital and perianal warts, cancer, and COVID-19 [1] [2].
  • $33
In Stock
Size
QTY
Imiquimod
T013499011-02-6
Imiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
Imiquimod maleate
T22862896106-16-4
Imiquimod maleate (R 837 maleate) is a toll-like receptor 7 (TLR7) agonist and immune response modifier with antiviral and antitumor effects. Imiquimod maleate induces psoriatic-like skin lesions in mice and can be used to study various skin malignancies.
  • $29
In Stock
Size
QTY